Increased elevated plus maze open-arm time in mice during spontaneous morphine withdrawal

Behavioural Brain Research

Volumn 197, Issue 2, 2009, Pages 454-456

  Buckman, Sam G ^a   Hodgson, Stephen R ^a   Hofford, Rebecca S ^a   Eitan, Shoshana ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Anxiety; Dependence; Escape behaviors; Opioid

Indexed keywords

MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DRUG EFFECT; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; INJECTIONS, SUBCUTANEOUS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MORPHINE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 58149352551     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.09.035     Document Type: Article

References (30)

1. American Psychiatric Association DSM-IV. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
2. Lowinson J.H., Ruiz P., Millman R.B., and Langrod J.G. Substance abuse: a comprehensive textbook (1997), Williams and Wilkins, Baltimore
3. Schulteis G., and Koob G.F. Reinforcement processes in opiate addiction: a homeostatic model. Neurochem Res 21 (1996) 1437-1454
4. Aston-Jones G., and Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47 (2004) 167-179
5. Koob G.F., and Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 8 (2005) 1442-1444
6. Schulteis G., Yackey M., Risbrough V., and Koob G.F. Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharmacol Biochem Behav 60 (1998) 727-731
7. Harris G.C., and Aston-Jones G. Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology (Berl) 113 (1993) 131-136
8. Harris A.C., and Gewirtz J.C. Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety. Psychopharmacology (Berl) 171 (2004) 140-147
9. Zhang Z., and Schulteis G. Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze. Pharmacol Biochem Behav 89 (2008) 392-403
10. Hodgson SR, Hofford RC, Norris CJ, Eitan S. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal. Behav Pharmacol; in press.
11. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
12. Eitan S., Bryant C.D., Saliminejad N., Yang Y.C., Vojdani E., Keith Jr. D., Polakiewicz R., and Evans C.J. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci 23 (2003) 8360-8369
13. Hodgson SR, Hofford RC, Wellman PJ, Eitan S. Different affective response to opioid withdrawal in adolescent and adult mice. Life Sci; in press.
14. Handal M., Grung M., Skurtveit S., Ripel A., and Mørland J. Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity. Pharmacol Biochem Behav 73 (2002) 883-892
15. Kalvass J.C., Olson E.R., Cassidy M.P., Selley D.E., and Pollack G.M. Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50, u and correlation of in vitro, preclinical, and clinical data. J Pharmacol Exp Ther 323 (2007) 346-355
16. Kudryavtseva N.N., Gerrits M.A., Avgustinovich D.F., Tenditnik M.V., and Van Ree J.M. Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice. Peptides 25 (2004) 1355-1363
17. Motta V., Penha K., and Brandão M.L. Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test. Psychopharmacology (Berl) 120 (1995) 470-474
18. Zarrindast M.R., Babapoor-Farrokhran S., Babapoor-Farrokhran S., and Rezayof A. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci 82 (2008) 1175-1181
19. Calenco-Choukroun G., Daugé V., Gacel G., Féger J., and Roques B.P. Opioid delta agonists and endogenous enkephalins induce different emotional reactivity than mu agonists after injection in the rat ventral tegmental area. Psychopharmacology (Berl) 103 (1991) 493-502
20. Wilson M.A., and Junor L. The role of amygdalar mu-opioid receptors in anxiety-related responses in two rat models. Neuropsychopharmacology 33 (2008) 2957-2968
21. Maldonado C., Rodríguez-Arias M., Aguilar M.A., and Miñarro J. GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice. Psychopharmacology (Berl) 177 (2004) 130-140
22. Broseta I., Rodriguez-Arias M., Aguilar M.A., and Minarro J. Isolation decreases physical and motivational aspects of morphine withdrawal. Behav Pharmacol 16 (2005) 131-138
23. Shoblock J.R., and Maidment N.T. Constitutively active mu opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. Neuropsychopharmacology 31 (2006) 171-177
24. Budziszewska B., Jaworska-Feil L., and Lasoń W. Neurosteroids and the naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur Neuropsychopharmacol 6 (1996) 135-140
25. Rodgers R.J., and Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 21 (1997) 801-810
26. Weiss S.M., Wadsworth G., Fletcher A., and Dourish C.T. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Neurosci Biobehav Rev 23 (1998) 265-271
27. Wall P.M., and Messier C. Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci Biobehav Rev 25 (2001) 275-286
28. Carobrez A.P., and Bertoglio L.J. Ethological temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 29 (2005) 1193-1205
29. Einat H., and Manji H.K. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 59 (2006) 1160-1171
30. Laviola G., Macrì S., Morley-Fletcher S., and Adriani W. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev 27 (2003) 19-31